University of Thessaly (UTH)
Προοπτική αξιολόγηση της ποιότητας ζωής ασθενών με πνευμονική ίνωση
Abstract
dc:descriptionBackground: Idiopathic pulmonary fibrosis (IPF) is a progressive debilitating lung disease, which affects physical and mental wellbeing. The Idiopathic Pulmonary Fibrosis Patient-Reported Outcome Measure (IPF-PROM) scale is a validated and reliable tool for the self-report of physical and psychological wellbeing in IPF.Aims and Objectives: This study aimed to validate a Greek version of the IPF-PROM scale and further investigate its correlation with clinical features of IPF patients and its interrelation with depressive symptoms and health-related quality of life (HRQoL). An additional objective was to evaluate the change in total IPF-PROM scores across three consecutive time points within a stable patient cohort during the study period.Methods: This was a two-centre, observational, cross-sectional study, in which IPF patients completed three scales: IPF-PROM, Patient Health Questionnaire-9 (PHQ-9), an index of depressive symptoms, and Health Survey Questionnaire Short Form-12 (SF-12), an index of HRQoL, at the IPF Outpatient Clinics of two University Hospitals in Greece during 2023-2024. Logistic regression analysis was conducted to assess severe status of IPF-PROM compared to mild/moderate status as well as a multiple linear regression analysis was also implemented of mean Δ-change of IPF-PROM total score levels (the II & III phases from I phase) in relation IPF patients’ characteristics and symptoms, signs or duration of IPF.Results: The study involved 136 IPF patients (87.9% males) with a mean age of 73.5 ± 7.9 years. The consistency of the responses of the IPF-PROM scale was assessed using Cronbach’s alpha coefficient and was estimated in total (α = 0.972) as well as in Breathlessness/Fatigue (α = 0.967) and in Psychological Wellbeing (α = 0.966). Patients were classified overall with moderate disease according to IPF-PROM mean scores (41.7 ± 31.3), particularly in the combined Breathlessness/Fatigue and the Psychological Wellbeing components (40.1 and 43.8, respectively, p > 0.050). Patients with severe symptoms, as measured by IPF-PROM, scored higher levels of depressive symptoms on PHQ-9 compared to those with moderate or mild symptoms (17.1, 12.3, and 1.4, respectively, p < 0.001) and lower levels of HRQoL in physical (32.6, 34.7, and 47.9, p < 0.001) and mental health on SF-12 (23.9, 34.5, and 50.3, p < 0.001). Patients with incrementally higher levels of oxygen saturation had lower odds for severe health status according to IPF-PROM (OR = 0.83, p = 0.018). Furthermore, assessment of Δ-changes across consecutive phases I, II, and III revealed that married status was associated with positive changes (increases) in IPF-PROM scores (β=31.0, p = 0.035). Conversely, a higher prevalence of the seven clustered IPF-related factors (e.g., symptoms, clinical signs, and disease duration) was found to predict a greater decline in IPF-PROM scores during phases II and III (β=-9.68, p<0.001).Conclusions: A significant percentage of IPF patients present with impaired health status and symptoms suggestive of depression. The IPF-PROM scale represents a useful tool that may predict impairment of mental health and HRQoL in IPF, with potential utility for clinical practice and research. This study also reveals the need for multidisciplinary patient care in the management of IPF.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tziraki, Maria
- Τζιράκη, Μαρία
Subjects
dc:subject × 21- Πνευμονική ίνωση
- Ποιότητα ζωής
- Αναφερόμενες από τους ασθενείς εκβάσεις
- IPF-PROM
- Διαπολιτισμική προσαρμογή
- Ψυχομετρική επικύρωση
- Αξιοπιστία και εγκυρότητα
- Προοπτική μελέτη
- Pulmonary fibrosis
- Quality of life
- Patient-reported outcomes
- Cross-cultural adaptation
- Psychometric validation
- Reliability and validity
- Prospective study
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Πνευμονολογία και Αναπνευστικές παθήσεις
- Clinical Medicine
- Medical and Health Sciences
- Pulmonary and Respiratory Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62884